Prevalence of CYP2C19 Gene Polymorphism in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Prevalence of CYP2C19 Gene Polymorphism in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Saved in:

Bibliographic Details
Main Authors:	Maya Rosana Amalia, Susi Herminingsih
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2021-12-01
Series:	European Cardiology Review
Online Access:	https://www.ecrjournal.com/articleindex/ecr.2021.16.PO5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

Prognostic factors for stent restenosis in patients with coronary artery disease undergoing percutaneous coronary intervention
by: M. А. Meshkova, et al.
Published: (2025-06-01)

Regional aspects of associations of the CYP2C19 gene polymorphism with coronary atherosclerosis in acute coronary syndrome
by: K. Yu. Nikolaev, et al.
Published: (2018-11-01)

Characteristics of patients with coronary artery disease and type 2 diabetes mellitus undergoing elective percutaneous coronary intervention
by: Anastasiya G. Neeshpapa, et al.
Published: (2025-01-01)

Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: A. V. Panov
Published: (2021-09-01)

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes
by: Ryaan EL‐Andari, et al.
Published: (2025-06-01)

Percutaneous Coronary Intervention in Anomalous Right Coronary Artery: Ready to Implement in Clinical Routine?
by: Anselm W Stark, et al.
Published: (2022-10-01)

Periinterventional cardiovascular risk and the methods for its reduction in coronary heart disease patients undergoing percutaneous coronary intervention
by: K. A. Nazarova, et al.
Published: (1970-01-01)

Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
by: A. V. Svarovskaya, et al.
Published: (2020-07-01)

Prognostic Effect of pan-Immune-Inflammation Value Indices in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Yan Liu MM, et al.
Published: (2025-05-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Syphilitic Coronary Artery Ostial Stenosis Resulting in Acute Myocardial Infarction Treated by Percutaneous Coronary Intervention
by: Marcelo A. Nakazone, et al.
Published: (2010-01-01)

Epidemiological Profile of Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome in a Single Tertiary Center in Basrah, Iraq
by: Ola Murtadaa Albattat, et al.
Published: (2025-06-01)

THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01)

CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
by: O. Iu. Mironova, et al.
Published: (2020-12-01)

The Role of Endothelin‐1, Kidney Function and Diabetes in Patients With Coronary Artery Disease Underwent Percutaneous Coronary Intervention
by: Zixiang Ye, et al.
Published: (2025-07-01)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021-05-01)

Sequential percutaneous intervention for sinus venosus defect and significant coronary artery disease
by: Bojja Venkata Satya Roopesh, et al.
Published: (2024-11-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

Phenotyping the Use of Cangrelor in Percutaneous Coronary Interventions
by: Nikolaos Pyrpyris, et al.
Published: (2025-03-01)

An Anomalous Right Coronary Artery Originating from the Left Anterior Descending Artery, a Case Report of Successful Percutaneous Coronary Intervention
by: Ebrahim Nematipour, et al.
Published: (2025-08-01)

ASSOCIATION OF HIGH LIPOPROTEIN(a) LEVELS WITH CORONARY ARTERY PATENCY DURING THE FIRST YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS
by: M. V. Ezhov, et al.
Published: (2014-07-01)

Influence of multimorbidity on the risk of events in men with chronic coronary artery disease after myocardial infarction and percutaneous coronary intervention
by: D. V. Dedov, et al.
Published: (2023-12-01)

PREVALENCE OF POLYMORPHOUS LOCUS 681G>A OF CYP2C19 GENE IN RUSSIAN POPULATION
by: T. A. Bairova, et al.
Published: (2014-11-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

CLOPIDOGREL RESPONSE IN ACUTE CORONARY SYNDROME PATIENTS WITH CYP2Y12*2 AND CYP2Y12*3 POLYMORPHISMS
by: R. Rahmatini, et al.
Published: (2018-04-01)

Hemoglobin, albumin, lymphocyte, and platelet (HALP) score predict prognosis in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention
by: Yijing Xin, et al.
Published: (2025-07-01)

High-maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
by: Yu Chen, et al.
Published: (2013-01-01)

Non-Dipping Pattern Is Associated with Periprocedural Myocardial Infarction in Hypertensive Patients Undergoing Elective Percutaneous Coronary Intervention
by: Ozkan Bekler, et al.
Published: (2025-04-01)

Myosteatosis predicts the prognosis of patients with ST-elevation myocardial infarction who undergo emergency percutaneous coronary intervention
by: Junqian Wang, et al.
Published: (2025-03-01)

Nicorandil in the prevention of cardiac damage and type 4A myocardial infarction with planned percutaneous coronary intervention in patients with atherosclerosis of coronary arteries
by: G. N. Soboleva, et al.
Published: (2019-06-01)

Association of cell-free DNA with the length of ulcerated plaque in the infarct-related artery and the myocardial infarct size among patients with ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
by: I. A. Zaigraev, et al.
Published: (2024-10-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Results of percutaneous transluminal coronary angioplasty and coronary stenting during the first post-intervention year
by: R. T. Libenzon, et al.
Published: (2006-02-01)

Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
by: Muli Wu, et al.
Published: (2013-01-01)

Impact of drug eluting stents’ length and diameter on short term outcome in patients undergoing primary percutaneous coronary intervention
by: Abdel-Galeel Ahmed, et al.
Published: (2025-03-01)

Robotic Percutaneous Coronary Intervention: The Good, the Bad, and What is to Come
by: Laura Young, et al.
Published: (2022-01-01)